Nanjing Medical Company Limited announced that it plans to issue up to 55 million A shares through private placement to no more than 10 investors, including Nanjing Medical Group, the controlling shareholder of the Company. Nanjing Medical Group plans to subscribe 21% of the privately issued shares.